Surgical management of metastatic Hürthle cell carcinoma to the skull base, cortex, and spine: illustrative case

• DOI: 10.3171/case23263
• Publication Date: 2023-10-10T00:29:25Z
• Authors: N. U. Farrukh Hameed; Meagan M Hoppe; Ahmed Habib; Jeffrey Head; Regan Shanahan; Bradley A Gross; Sandra Narayanan; Georgios Zenonos; Pascal Zinn
• Keywords: Case Lesson; 3. Good health

Hürthle cell carcinoma (HCC) is an unusual and aggressive variant of the follicular type differentiated thyroid cancer (DTC), accounting for less than 3% DTCs but posing highest risk metastasis. Brain metastases are uncommonly reported in literature pose a poor prognosis. The low rate brain from HCC coupled with ambiguous treatment protocols extracranial disease complicate successful management definitive strategy. authors present case patient metastasis to skull base, cortex, spine recent tibial metastasis.Despite presence spine, responded very well radiation therapy, sellar mass resection, cervical decompression fixation has made remarkable recovery.The authors' multidisciplinary approach patient's care, including diverse team specialists oncology, neurosurgery, orthopedic surgery, radiology, endocrinology, collaboration clinical trial researchers, was fundamental her outcome, demonstrating utility intersecting specialties outcomes neuro-oncological care.